TSXV - Delayed Quote CAD

Conavi Medical Corp. (CNVI.V)

0.4050
-0.0250
(-5.81%)
At close: May 15 at 3:52:22 PM EDT
Loading Chart for CNVI.V
  • Previous Close 0.4300
  • Open 0.4350
  • Bid 0.4000 x --
  • Ask 0.4250 x --
  • Day's Range 0.4050 - 0.4350
  • 52 Week Range 0.3600 - 1.5200
  • Volume 66,636
  • Avg. Volume 40,068
  • Market Cap (intraday) 17.921M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

conavi.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: CNVI.V

View More

Performance Overview: CNVI.V

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CNVI.V
37.69%
S&P/TSX Composite index (^GSPTSE)
5.19%

1-Year Return

CNVI.V
67.60%
S&P/TSX Composite index (^GSPTSE)
16.21%

3-Year Return

CNVI.V
67.60%
S&P/TSX Composite index (^GSPTSE)
28.84%

5-Year Return

CNVI.V
67.60%
S&P/TSX Composite index (^GSPTSE)
76.91%

Compare To: CNVI.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNVI.V

View More

Valuation Measures

As of 5/15/2025
  • Market Cap

    17.92M

  • Enterprise Value

    32.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -98.23%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.16M

  • Net Income Avi to Common (ttm)

    -43.62M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    436k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -16.88M

Research Analysis: CNVI.V

View More

People Also Watch